search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
HELPING TO PREVENT THE NEXT PANDEMIC: THE ABBOTT PANDEMIC DEFENSE COALITION


HOW DO WE STOP HISTORY FROM REPEATING ITSELF?


This first-of-its-kind* global network is dedicated to detecting and identifying viral threats. Meet the teams who are working around the world to help prevent the next pandemic.


Abbott Rush University


CHICAGO, U.S.


Centre for Epidemic Response and Innovation


STELLENBOSCH, SOUTH AFRICA


Colombia/Wisconsin One Health Consortium at the Universidad Nacional de Colombia


MEDELLÍN, COLOMBIA


National Center for Disease Control and Public Health


TBILISI, GEORGIA


YRG Care CHENNAI, INDIA


Fiocruz RIO DE JANEIRO, BRAZIL


HOW IT WORKS: THE COALITION’S ACTION PLAN


they can’t diagnose, it can be the first sign of a new threat.


1 4 © 2022 Abbott. All rights reserved. Any photos displayed are for illustrative purposes only. Any person depicted in such photos may be a model. ADD-138329-EMEA-EN 03/22


When doctors identify patients with unknown conditions that


undergo further analysis to see if we’ve seen the virus before.


2


If a threat is discovered, the viral sequence and prototype diagnostic test will be immediately


shared so that science and public health can collaborate to understand risk level and pandemic potential.


*The Abbott Pandemic Defense Coalition is the first company-led global scientific and public health network dedicated to helping prevent and diminish future pandemic threats.


We’ll deploy diagnostic testing to the extent possible to assist in efforts to contain the virus before it can reach pandemic levels.


5


The patient samples are sent to a coalition member — they’ll


3


We’ll conduct genetic sequencing, which will identify


characteristics that may indicate a new threat.


KRISP, Genomic Centre of the University of KwaZulu-Natal


DURBAN, SOUTH AFRICA


Uganda Virus Research Institute


ENTEBBE, UGANDA


Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation (IRESSEF)


DAKAR, SENEGAL


Faculty of Medicine Siriraj Hospital, Mahidol University


BANGKOK, THAILAND


Universidade de São Paulo


SÃO PAULO, BRAZIL


Université Quisqueya PORT-AU-PRINCE, HAITI


University of Zimbabwe HARARE, ZIMBABWE


The University of the West Indies


MONA, JAMAICA


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63